Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)

被引：0
|
作者：
Inderdeep Dhaliwal
Shayan Kassirian
Michael A. Mitchell
Mehdi Qiabi
Andrew Warner
Alexander V. Louie
Harvey H. Wong
Christine M. McDonald
Jason Rajchgot
David A. Palma
机构：
[1] Western University,Division of Respirology, Department of Medicine, London Health Sciences Centre
[2] Western University,Division of Thoracic Surgery, Department of Surgery, London Health Sciences Centre
[3] Western University,Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre
[4] University of Toronto,Division of Radiation Oncology, Department of Oncology, Sunnybrook Health Sciences Centre
[5] University of Toronto,Division of Respirology, Department of Medicine, Sunnybrook Health Sciences Centre
来源：
BMC Cancer | / 22卷
关键词：
Stereotactic ablative radiotherapy (SABR); Non-small cell lung cancer (NSCLC); Endobronchial ultrasound (EBUS); Endoscopic ultrasound (EUS); Oligometastatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
    Dhaliwal, Inderdeep
    Kassirian, Shayan
    Mitchell, Michael A.
    Qiabi, Mehdi
    Warner, Andrew
    Louie, Alexander, V
    Wong, Harvey H.
    McDonald, Christine M.
    Rajchgot, Jason
    Palma, David A.
    BMC CANCER, 2022, 22 (01)
  • [2] SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)
    Mak, Ka-Man
    McDonald, Fiona
    Teague, Jonathan
    Faivre-Finn, Corinne
    Forster, Martin
    Hanna, Gerard
    Moinuddin, Syed
    Conibear, John
    Harden, Susan
    Popat, Sanjay
    Califano, Raffaele
    Farrelly, Laura
    Counsell, Nicholas
    Saron, T. M. G.
    LUNG CANCER, 2022, 165 : S71 - S71
  • [3] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
  • [4] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [5] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [6] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [7] Feasibility of Stereotactic Ablative Radiotherapy (SABR) for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)
    Woodford, Katrina
    Panettieri, Vanessa
    Trieumy Tran Le
    Senthi, Sashendra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1467 - S1468
  • [8] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
    Dohopolski, Michael
    Iyengar, Puneeth
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
  • [9] To SABR or Not to SABR? Indications and Contraindications for Stereotactic Ablative Radiotherapy in the Treatment of Early-Stage, Oligometastatic, or Oligoprogressive Non-Small Cell Lung Cancer
    Shultz, David Benjamin
    Diehn, Maximilian
    Loo, Billy W., Jr.
    SEMINARS IN RADIATION ONCOLOGY, 2015, 25 (02) : 78 - 86
  • [10] Is stereotactic ablative radiotherapy (SABR) a safe treatment for multiple primary lung cancer (MPLC) non-small cell lung cancer (NSCLC)?
    Murray, P. F.
    Spencer, K.
    Snee, M.
    Dickinson, P.
    Jain, P.
    Clarke, K.
    Franks, K.
    LUNG CANCER, 2016, 91 : S48 - S48
12345